The safety of bone-marrow derived mesenchymal stem cells in patients with type 2 diabetes mellitus
The potential role of mesenchymal stem cells (MSCs) in the management of Type 2 diabetes mellitus (T2DM) has been shown with varying degrees of success in animal models and in…